Examination of B Cell Responses in Human Blood
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00806845
- Lead Sponsor
- Regenerative Medicine Network
- Brief Summary
The aim of this study is the assessment B-cell immune responses in HIV-infected individuals.
- Detailed Description
Groups of patients with different immune competencies will be examined. The impact of HIV infection on immune response will be assessed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- HIV-infected individuals
- controls
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antigen specific B-cell responses 18 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie B-cell immune responses in HIV-infected individuals as studied in NCT00806845?
How do B-cell responses in NCT00806845 compare to standard-of-care treatments for HIV Infections?
What biomarkers are associated with B-cell immune response variability in HIV-infected patients from NCT00806845?
What adverse events were observed in B-cell assessment studies of HIV-infected individuals like NCT00806845?
How does the Regenerative Medicine Network's observational study NCT00806845 contribute to understanding HIV-related immune dysfunction?
Trial Locations
- Locations (1)
Universität Leipzig
🇩🇪Leipzig, Sachsen, Germany
Universität Leipzig🇩🇪Leipzig, Sachsen, Germany